FDA Approves Gene Therapy That Lets Deaf Children Hear

A baby named Miles couldn't hear a jet engine even if it roared right next to him. Today, after a single treatment at 13 months old, his hearing is completely normal.

The FDA approved Otarmeni on Thursday, making it the first gene therapy to restore normal hearing in children born deaf. The treatment fixes a rare form of deafness called otoferlin, caused by a single gene mutation that destroys a protein needed to send sound signals to the brain.

Here's the part that made doctors emotional: Regeneron, the company behind this breakthrough, is providing the therapy completely free to any child who needs it. No price tag. No insurance battles. Just access for every family.

"We wanted to make a statement," said Dr. George Yancopoulos, Regeneron's chief scientific officer. The company learned from other gene therapies priced in the millions that sky-high costs mean kids who need help don't get it.

Until now, the only option for these children was a cochlear implant. Those devices help, but they don't restore normal hearing. Sound comes through tinny and robotic. Kids struggle in noisy rooms, can't hear high pitches, and go deaf every night while recharging batteries.

The gene therapy works differently. Doctors deliver a working copy of the otoferlin gene directly into the inner ear's hair cells. About 80 percent of children treated in trials can now hear well enough to skip cochlear implants entirely. Around 30 percent, like Miles, have completely normal hearing.

Otoferlin deafness only accounts for 2 to 8 percent of children born deaf. But doctors say this moment changes everything.

The Ripple Effect

Scientists now know that reversing genetic deafness is possible. More than 150 genes cause hearing loss, with thousands of different mutations. Teams are already racing to develop treatments for GJB2 mutations, which cause 20 percent of congenital hearing loss.

Dr. Dylan Chan, a pediatric ear specialist at UC San Francisco, called it historic. "This is the first time in history that there has been a medical therapy that has enabled deaf children to hear," he said.

Dr. Daniel Lee at Massachusetts Eye and Ear put it simply: "We have now entered the era of biological treatment for inner ear hearing loss."

Miles's mother, who asked to remain anonymous to protect her son's privacy, said the therapy "completely changed our lives." She watched her baby go from profound deafness to giggling at sounds most of us take for granted.

Four companies worldwide are now developing similar treatments, and researchers are mapping out which forms of genetic deafness to tackle next. What started as one rare condition could eventually help hundreds of thousands of children hear their parents' voices, their favorite songs, and the world around them.